IL2 and neoplasm: Flow cytometric analysis of tumor‐infiltrating T cells revealed a decrease in the frequency of PD‐1+Tim‐3+ CD45.1+ OT‐I T cells in the FPC2‐IG‐IL‐2 treated group.